The network adds five additional research sites, expanding its foothold across North America and its wide range of therapeutic area capabilities

该网络增加了五个额外的研究站点，扩大了其在北美的立足点及其广泛的治疗领域能力

TORONTO, ON and Morehead City, NC – December 13, 2023 – Centricity Research, one of North America’s largest clinical research networks with headquarters in Columbus, Georgia and Toronto, Ontario, has announced that it has acquired Morehead City, North Carolina-based Lucas Research, extending the organization’s reach and capabilities..

安大略省多伦多市和北卡罗来纳州莫尔黑德市–2023年12月13日–Centricity Research是北美最大的临床研究网络之一，总部位于佐治亚州哥伦布市和安大略省多伦多市，它宣布收购了位于北卡罗来纳州莫尔黑德市的Lucas Research，扩大了该组织的影响力和能力。。

Operating five research sites in North Carolina – in Morehead City, New Bern and Hickory – Lucas Research is the fifth clinical research company to join Centricity Research since the organization launched in November 2021 following the merger of industry leaders IACT Health and LMC Manna Research.

Lucas research在北卡罗莱纳州的Morehead City、New Bern和Hickory运营着五个研究点，是继行业领导者IACT Health和LMC Manna research于2021年11月合并后加入Centricity research的第五家临床研究公司。

With this acquisition, Centricity now offers contract research organizations (CROs) and sponsors access to more than 35 clinical research sites, reaching 8.5 million geographically and ethnically-diverse patients, and over 155 experienced investigators who perform trials in more than 20 therapeutic areas, including infectious disease, neurology, endocrinology, oncology, cardiology, dermatology, vaccines and more. .

通过此次收购，Centricity现在为合同研究组织（CRO）和赞助商提供了超过35个临床研究站点的访问权限，覆盖了850万不同地理和种族的患者，以及超过155名经验丰富的研究人员，他们在20多个治疗领域进行了试验，包括传染病，神经病学，内分泌学，肿瘤学，心脏病学，皮肤病学，疫苗等。。

“We’re thrilled to combine forces with the phenomenal team at Lucas Research, which will help strengthen our phase 1 clinical trial capabilities, geographic reach, and operational expertise as we forge ahead with our mission to advance medical knowledge and develop better medications,” said Dr. Jeff Kingsley, Chief Corporate Development Officer of Centricity Research..

Centricity Research首席企业发展官杰夫·金斯利（Jeff Kingsley）博士说：“我们很高兴能与卢卡斯研究院（Lucas Research）的杰出团队联合起来，这将有助于加强我们的第一阶段临床试验能力、地理范围和运营专业知识，以推进我们的医学知识进步和开发更好的药物。”。。

“Lucas Research shares Centricity’s customer and team-centric focus, and its exceptional track record of patient recruitment will undoubtedly accelerate our efforts to revolutionize research and change lives,” added Will Furness, CEO of Centricity Research.

Centricity Research首席执行官威尔·弗内斯（will Furness）补充道：“卢卡斯研究公司（Lucas Research）与Centricity一样，以客户和团队为中心，其出色的患者招募记录无疑将加速我们革新研究和改变生活的努力。”。

Founded in 2004 as a hybrid clinical research organization and medical practice, Lucas Research specializes in advancing research and treatments in immunology, inflammation, diabetes, weight loss and other endocrine diseases. With more than 70 team members who have completed over 250 clinical trials, its therapeutic areas include cardiovascular, endocrine and metabolic, gastroenterology, infectious disease and vaccines, respiratory and women’s health..

Lucas research成立于2004年，是一家混合临床研究机构和医疗机构，专门从事免疫学、炎症、糖尿病、减肥和其他内分泌疾病的研究和治疗。拥有70多名团队成员，完成了250多项临床试验，其治疗领域包括心血管、内分泌和代谢、肠胃病、传染病和疫苗、呼吸和妇女健康。。

“We will continue to offer our patients world class care, but now with the extensive resources of an international team to ensure that we are delivering the top advances in care,” said Lucas Research Principal Investigator Dr. Jeannie Lucas, a board-certified internist with a subspecialty in endocrinology, who co-founded the company with her husband, Lucas Research CEO Seth Medlin..

卢卡斯研究中心首席研究员珍妮·卢卡斯博士（JeannieLucas）表示：“我们将继续为患者提供世界一流的护理，但现在我们拥有国际团队的广泛资源，以确保我们在护理方面取得最大进展。”珍妮·卢卡斯博士是董事会认证的内分泌学内科医生，与丈夫卢卡斯研究中心首席执行官塞思·梅德林（SethMedlin）共同创建了该公司。。

“We’ve always been driven to build a team that can change the world by serving our patients through research,” Medlin said. “Jeannie and I are thankful to have built a friendship and now partnership with Centricity Research that will allow us to take our vision for how we serve our community to the next level.”.

梅德林说：“我们一直致力于建立一个团队，通过研究为患者提供服务，从而改变世界。”。“Jeannie和我很感谢与Centricity Research建立了友谊和合作关系，这将使我们能够将如何为社区服务的愿景提升到一个新的水平。”。

About Centricity Research

关于中心性研究

Centricity Research is an integrated research organization with over 35 research offices across North America. The company conducts Phase I-IV clinical research in over 20 core therapeutic areas covering more than 100 health indications in inpatient and outpatient, pharmaceutical, biotechnology, and medical device trials.

Centricity Research是一家综合性研究组织，在北美拥有35多个研究办公室。该公司在20多个核心治疗领域进行I-IV期临床研究，涵盖住院和门诊、制药、生物技术和医疗器械试验的100多个健康适应症。

The organization’s founders have worked to revolutionize research for over 25 years by investing in the people and technology needed to deliver outstanding clinical trial experiences, earning numerous awards, including “Best Places to Work” and recognition for “Outstanding Diversity in Clinical Research.” For more information, visit https://www.centricityresearch.com/..

25年来，该组织的创始人通过投资于提供杰出临床试验经验所需的人员和技术，努力实现研究的革命性变革，获得了众多奖项，包括“最佳工作场所”和“临床研究杰出多样性”奖。有关更多信息，请访问https://www.centricityresearch.com/..

####

####

Media information and to set up interviews:

媒体信息和安排采访：

GBPR

GBPR

1-877-986-1340

1-877-986-1340

info@gailbergmanpr.com

info@gailbergmanpr.com